Interobserver variation in parotid gland delineation: A study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature

British Journal of Radiology

Volumn 85, Issue 1016, 2012, Pages 1070-1077

  Loo, Suat Wei ^a   Martin, W M C ^a   Smith, P ^a   Cherian, S ^a   Roques, T W ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFACT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; OROPHARYNX CARCINOMA; PAROTID GLAND; PAROTID GLAND DELINEATION; PAROTID GLAND DISEASE; RADIATION DOSE; RADIOLOGIST; REPRODUCIBILITY; SYSTEMATIC REVIEW;

CARCINOMA, SQUAMOUS CELL; CONE-BEAM COMPUTED TOMOGRAPHY; HUMANS; OBSERVER VARIATION; ORGAN SIZE; ORGAN SPARING TREATMENTS; OROPHARYNGEAL NEOPLASMS; PAROTID GLAND; RADIATION DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84864844180     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/32038456     Document Type: Article

References (71)

1. Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 1999;21:1-11. (Pubitemid 29006450)
2. Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 2002;94:1131-41. (Pubitemid 34150869)
3. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004;26:796-807. (Pubitemid 39159303)
4. McMillan AS, Pow EH, Leung WK, Wong MC, Kwong DL. Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma. J Oral Rehabil 2004;31:600-8. (Pubitemid 38834402)
5. Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:751-60. (Pubitemid 47418408)
6. Cooper JS, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 1995;31:1141-64.
7. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87. (Pubitemid 29462636)
8. Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-16. (Pubitemid 32184597)
9. Roesink JM, Schipper M, Busschers W, Raaijmakers CP, Terhaard CH. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. Int J Radiat Oncol Biol Phys 2005;63:1006-9. (Pubitemid 41505276)
10. Houweling AC, Philippens MEP, Dijkema T, Roesink JM, Terhaard CHJ, Schilstra C, et al. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2010;76:1259-65.
11. Braam PM, Terhaard CHJ, Roesink JM, Raaijmakers CPJ. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:975-80. (Pubitemid 44633513)
12. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873-9. (Pubitemid 350220416)
13. Hermans R, Feron M, Bellon E, Dupont P, Van den Bogaert W, Baert AL. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys 1998;40:553-7. (Pubitemid 28104224)
14. Van de Steene J, Linthout N, de Mey J, Vinh-Hung V, Claassens C, Noppen M, et al. Definition of gross tumor volume in lung cancer: inter-observer variability. Radiother Oncol 2002;62:37-49.
15. Caldwell CB, Mah K, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small cell lung tumors on CT: the impact of 18-FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 2001;51:923-31. (Pubitemid 33026421)
16. Tai P, Van Dyk J, Yu E, Battista J, Stitt L, Coad T. Variability of target volume delineation in cervical oesophageal cancer. Int J Radiat Oncol Biol Phys 1998;42:277-88. (Pubitemid 28502773)
17. Yamamoto M, Nagata Y, Okajima K, Ishigaki T, Murata R, Mizowaki T, et al. Differences in target outline delineation from CT scans of brain tumours using different methods and different observers. Radiother Oncol 1999;50:151-6. (Pubitemid 29155540)
18. Kouwenhoven E, Giezen M, Struikmans H. Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol 2009;54:2863-73.
19. Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001;61:275-80. (Pubitemid 33127232)
20. Pacholke HD, Amdur RJ, Morris CG, Li JG, Dempsey JF, Hinerman RW, et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 2005;28:351-8. (Pubitemid 41099539)
21. Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M, et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1309-17. (Pubitemid 46467154)
22. van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, Lamers EA, Balm AJ, Rasch CR. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008;3:41.
23. Hsiung CY, Ting HM, Huang HY, Lee CH, Huang EY, Hsu HC. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:454-61. (Pubitemid 44349039)
24. Munter MW, Hoffner S, Hof H, Herfarth KK, Haberkorn U, Rudat V, et al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. Int J Radiat Oncol Biol Phys 2007;67:651-9. (Pubitemid 46215873)
25. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007;29:211-20. (Pubitemid 46339317)
26. Rades D, Fehlauer F, Wroblesky J, Albers D, Schild SE, Schmidt R. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol 2007;43:535-43. (Pubitemid 46860347)
27. Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;66:966-74. (Pubitemid 44633520)
28. Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 2005;63:725-31. (Pubitemid 41400058)
29. Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C. Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope 2008;118:635-9. (Pubitemid 351496757)
30. Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys 2008;71:1158-66.
31. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57:61-70. (Pubitemid 36959739)
32. Nutting CM, Morden JP, Harrington KJ, Guerrero Urbano T, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36.
33. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-91. (Pubitemid 44633504)
34. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 2010;18:1061-79.
35. Rasch C, Eisbruch A, Remeijer P, Bos L, Hoogeman M, van Herk M, et al. Irradiation of paranasal sinus tumors, a delineation and dose comparison study. Int J Radiat Oncol Biol Phys 2002;52:120-7. (Pubitemid 34041567)
36. Rasch CRN, Steenbakkers RJHM, Fitton I, Duppen JC, Nowak PJCM, Pameijer FA, et al. Decreased 3D observer variation with matched CT-MRI, for target delineation in nasopharyngeal cancer. Radiat Oncol 2010;5:21.
37. Rasch C, Keus R, Pameijer FA, Koops W, de Ru V, Muller S, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997;39:841-8. (Pubitemid 27486072)
38. Chang CC, Chen MK, Wu HK, Liu MT. Nasopharyngeal carcinoma volume measurements determined with computed tomography: study of intraobserver and interobserver variability. J Otolaryngol 2002;31:361-5.
39. Riegel AC, Berson AM, Destian S, Ng T, Tena LB, Mitnick RJ, et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys 2006;65:726-32. (Pubitemid 43795841)
40. Cooper JS, Mukherji SK, Toledano AY, Beldon C, Schmalfuss IM, Amdur R, et al. An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658). Int J Radiat Oncol Biol Phys 2007;67:972-5.
41. Breen SL, Publicover J, De Silva S, Pond G, Brock K, O'Sullivan B, et al. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys 2007;68:763-70. (Pubitemid 46818731)
42. O'Daniel JC, Rosenthal DI, Garden AS, Barker JL, Ahamad A, Ang KK, et al. The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy. Am J Clin Oncol 2007;30:191-8. (Pubitemid 46573256)
43. Geets X, Daisne JF, Arcangeli S, Coche E, De Poel M, Duprez T, et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI. Radiother Oncol 2005;77:25-31. (Pubitemid 41503385)
44. Gardner M, Halimi P, Valinta D, Plantet MM, Alberini JL, Wartski M, et al. Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation. Head Neck 2009;31:461-7.
45. Astreinidou E, Dehnad H, Terhaard CH, Raaijmakers CP. Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 2004;58:124-31. (Pubitemid 38010345)
46. Vineberg KA, Eisbruch A, Coselmon MM, McShan DL, Kessler ML, Fraass BA. Is uniform target dose possible in IMRT plans in the head and neck? Int J Radiat Oncol Biol Phys 2002;52:1159-72. (Pubitemid 34296477)
47. Moore KL, Brame RS, Low DA, Mutic S. Experience-based quality control of clinical intensity-modulated radiotherapy planning. Int J Radiat Oncol Biol Phys 2011;81:545-51.
48. Hunt MA, Jackson A, Narayana A, Lee N. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys 2006;66:296-304. (Pubitemid 44175676)
49. Roesink JM, Moerland MA, Battermann JJ, Hordijk GJ, Terhaard CH. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 2001;51:938-46. (Pubitemid 33026423)
50. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
51. Castadot P, Geets X, Lee JA, Christian N, Gregoire V. Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiother Oncol 2010;95:209-17.
52. Barker JL Jr, Garden AS, Ang KK, O'Daniel JC, Wang H, Court LE, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004;59:960-70. (Pubitemid 38834288)
53. Han C, Chen YJ, Liu A, Schultheiss TE, Wong JY. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1256-62.
54. Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Kirwan J, et al. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope 2009;119:1966-74.
55. Hong TS, Tome WA, Chappell RJ, Chinnaiyan P, Mehta MP, Harari PM. The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;61:779-88. (Pubitemid 40247973)
56. O'Daniel JC, Garden AS, Schwartz DL, Wang H, Ang KK, Ahamad A, et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys 2007;69:1290-6. (Pubitemid 47625863)
57. Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, et al. Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol 2008;89:81-8.
58. Robar JL, Day A, Clancey J, Kelly R, Yewondwossen M, Hollenhorst H, et al. Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007;68:1121-30. (Pubitemid 47048570)
59. Manning MA, Wu Q, Cardinale RM, Mohan R, Lauve AD, Kavanagh BD, et al. The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:1400-9. (Pubitemid 33116335)
60. Delana A, Menegotti L, Bolner A, Tomio L, Valentini A, Lohr F, et al. Impact of residual setup error on parotid gland dose in intensity-modulated radiation therapy with or without planning organ-at-risk margin. Strahlenther Onkol 2009;185:453-9.
61. Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 2009;75:924-32.
62. Schwartz DL, Dong L. Adaptive radiation therapy for head and neck cancer - can an old goal evolve into a new standard? J Oncol 2011;2011:article ID 690595
63. Wong EK, Truong PT, Kader HA, Nichol AM, Salter L, Petersen R, et al. Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines. Int J Radiat Oncol Biol Phys 2006;66:372-6. (Pubitemid 44332757)
64. van Mourik AM, Elkhuizen PH, Minkema D, Duppen JC, Dutch Young Boost Study Group, van Vliet-Vroegindeweij C. Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother Oncol 2010;94:286-91.
65. Fuller CD, Nijkamp J, Duppen JC, Rasch CRN, Thomas Jr CR, Wang SJ, et al. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys 2011;79:481-9.
66. van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol 2009;93:545-52.
67. Tai P, Van Dyk J, Battista J, Yu E, Stitt L, Tonita J, et al. Improving the consistency in cervical esophageal target volume definition by special training. Int J Radiat Oncol Biol Phys 2002;53:766-74. (Pubitemid 34626518)
68. Reed VK, Woodward WA, Zhang L, Strom EA, Perkins GH, Tereffe W, et al. Automatic segmentation of whole breast using atlas approach and deformable image registration. Int J Radiat Oncol Biol Phys 2009;73:1493-500.
69. Stapleford LJ, Lawson JD, Perkins C, Edelman S, Davis L, McDonald MW, et al. Evaluation of automatic atlas-based lymph node segmentation for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010;77:959-66.
70. Chao KSC, Bhide S, Chen H, Asper J, Bush S, Franklin G, et al. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys 2007;68:1512-21. (Pubitemid 47176829)
71. Petersen RP, Truong PT, Kader HA, Berthelet E, Lee JC, Hilts ML, et al. Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys 2007;69:41-8. (Pubitemid 47247509)